Eleison Pharmaceuticals Inc, based in Princeton, NJ, is a pioneering biopharmaceutical company dedicated to developing uncommon therapies for rare and life-threatening cancers. With a strong focus on providing new hope for patients with uncommon diseases, Eleison's product pipeline offers innovative solutions to address unmet medical needs.
Driven by the belief that every patient with a rare cancer is worth fighting for and investing in, Eleison Pharmaceuticals is committed to advancing the field of oncology through cutting-edge research and clinical trials. With a dedicated team of experts and a focus on investor relations, Eleison strives to make a significant impact in the lives of patients and their families.
Generated from the website
